首页>
外国专利>
THE USE OF CONCENTRATES CONTAINING vWF FACTOR AS A COMBINATION TREATMENT WHEN TREATING ANTI-THROMBOTIC AND FIBRINOLYTIC
THE USE OF CONCENTRATES CONTAINING vWF FACTOR AS A COMBINATION TREATMENT WHEN TREATING ANTI-THROMBOTIC AND FIBRINOLYTIC
展开▼
机译：治疗抗血栓和纤维蛋白溶蛋白时，将包含vWF因子的浓缩液作为联合治疗
展开▼
页面导航
摘要
著录项
相似文献
摘要
Use of von Willebrand factor (vWF) or fragments with vWF activity is claimed as an antidote to bleeding caused by administration of antithrombotic or fibrinolytic agents. Also claimed is a compsn. contg. (A) an antithrombotic and/or fibrinolytic agent; and (B) vWF or fragments with vWF activity.
展开▼
